Skip to main content
رجوع
CHGCF logo

Chugai Pharmaceutical Co., Ltd.

جودة البيانات: 100%
CHGCF
OTC Healthcare Drug Manufacturers - General
KWD 52.09
▼ KWD 1.22 (-2.28%)
القيمة السوقية: 85.72B
مُدرج أيضًا باسم CHGCY OTC
نطاق اليوم
KWD 52.09 KWD 54.44
نطاق 52 أسبوعًا
KWD 38.76 KWD 72.30
حجم التداول
216
متوسط 50 يوم / 200 يوم
KWD 58.19 / KWD 51.05
الإغلاق السابق
KWD 53.31

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 0.2 0.2
P/B 0.0 3.0
ROE % 22.1 3.5
Net Margin % 34.5 3.8
Rev Growth 5Y % 5.9 9.7
D/E 0.0 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 531.16
KWD 488.31 – KWD 574.26
1.92T 5
FY2029 KWD 481.84
KWD 442.97 – KWD 520.94
1.86T 2
FY2028 KWD 392.11
KWD 360.48 – KWD 423.93
1.62T 5

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-01-29 KWD 74.04 KWD 0.50 -99.3%
2025-07-24 KWD 0.51 KWD 0.41 -20.7%
2025-04-24 KWD 0.34 KWD 0.41 +21.7%
2025-01-30 KWD 0.00 KWD 0.36 +14933.5%
2024-10-25 KWD 0.45 KWD 0.44 -2.9%
2024-07-25 KWD 0.34 KWD 0.44 +30.2%
2024-04-24 KWD 0.27 KWD 0.29 +5.4%
2024-02-01 KWD 0.33 KWD 0.38 +15.2%

Dividend History

7 yr streak

Yield

0.02%

Payout Ratio

0.69%

Growth (3Y)

45.96%

Growth (5Y)

12.88%

Ex-Date Payment Date Amount Yield
Dec 31, 2026 Dec 29, 2026 KWD 0.42 1.60%
Jun 30, 2026 Jun 29, 2026 KWD 0.42 2.61%
Dec 31, 2025 Mar 27, 2026 KWD 0.94 3.29%
Jun 30, 2025 Aug 28, 2025 KWD 0.87 2.47%
Dec 31, 2024 Mar 28, 2025 KWD 0.36 1.48%
Jun 28, 2024 Aug 29, 2024 KWD 0.25 1.52%
Dec 28, 2023 Mar 29, 2024 KWD 0.28 1.51%
Jun 29, 2023 Aug 30, 2023 KWD 0.28 1.88%
Dec 29, 2022 Mar 31, 2023 KWD 0.30 2.20%
Jun 29, 2022 Aug 30, 2022 KWD 0.28 2.52%
Dec 29, 2021 Mar 30, 2022 KWD 0.40 2.08%
Jun 29, 2021 Aug 30, 2021 KWD 0.27 1.27%
Dec 29, 2020 Mar 24, 2021 KWD 0.29 1.02%
Jun 29, 2020 Aug 28, 2020 KWD 0.70 0.41%
Dec 27, 2019 Mar 31, 2020 KWD 0.84 6.03%
Jun 26, 2019 Aug 30, 2019 KWD 0.45 3.41%
Dec 26, 2018 Mar 29, 2019 KWD 0.50 2.79%
Jun 27, 2018 Aug 31, 2018 KWD 0.28 2.99%
Dec 27, 2017 Mar 23, 2018 KWD 0.29 3.71%
Jun 28, 2017 Sep 01, 2017 KWD 0.26 3.67%

النقاط الرئيسية

Revenue grew 5.93% annually over 5 years — modest growth
ROE of 22.11% indicates high profitability
Net margin of 34.50% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 313.45B in free cash flow
P/E of 0.20 — trading at a low valuation

النمو

Revenue Growth (5Y)
5.93%
Revenue (1Y)7.55%
Earnings (1Y)12.15%
FCF Growth (3Y)-3.37%

الجودة

Return on Equity
22.11%
ROIC21.85%
Net Margin34.50%
Op. Margin46.92%

الأمان

Debt / Equity
0.00
Current Ratio4.23
Interest Coverage575.24

التقييم

P/E Ratio
0.20
Forward P/E0.18
P/B Ratio0.04
EV/EBITDA-0.58
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 7.55% Revenue Growth (3Y) 6.44%
Earnings Growth (1Y) 12.15% Earnings Growth (3Y) 15.53%
Revenue Growth (5Y) 5.93% Earnings Growth (5Y) 9.42%
Profitability
Revenue (TTM) 1.26T Net Income (TTM) 434.39B
ROE 22.11% ROA 17.58%
Gross Margin 71.09% Operating Margin 46.92%
Net Margin 34.50% Free Cash Flow (TTM) 313.45B
ROIC 21.85% FCF Growth (3Y) -3.37%
Safety
Debt / Equity 0.00 Current Ratio 4.23
Interest Coverage 575.24
Dividends
Dividend Yield 0.02% Payout Ratio 0.69%
Dividend Growth (3Y) 45.96% Dividend Growth (5Y) 12.88%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio 0.20 Forward P/E 0.18
P/B Ratio 0.04 P/S Ratio 0.07
PEG Ratio 2.68 Forward PEG N/A
EV/EBITDA -0.58 Fwd EV/EBITDA -0.45
Forward P/S 0.06 Fwd Earnings Yield 555.56%
FCF Yield 365.66%
Market Cap 85.72B Enterprise Value -341.25B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.26T 1.17T 1.11T 1.26T 999.76B
Net Income 434.39B 387.32B 325.47B 374.43B 303.00B
EPS (Diluted) 263.95 235.36 197.80 227.57 184.17
Gross Profit 895.03B 831.20B 698.06B 783.70B 661.61B
Operating Income 590.71B 542.00B 439.17B 533.31B 421.90B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.47T 2.21T 1.93T 1.87T 1.54T
Total Liabilities 443.25B 306.87B 306.97B 445.37B 350.68B
Shareholders' Equity 2.03T 1.90T 1.63T 1.42T 1.19T
Total Debt 0.0 10.90B 13.46B 14.11B 16.04B
Cash & Equivalents 426.97B 540.20B 458.67B 222.17B 267.75B
Current Assets 1.74T 1.61T 1.37T 1.34T 1.06T
Current Liabilities 411.44B 290.36B 288.22B 423.73B 327.42B

درجات الاستراتيجيات

This stock passed the criteria for 3 strategies

Score = fit strength (0–100)
Rank = position among all matches
#510 of 826
36
#46 of 220
53
#192 of 203
17

النشاط الأخير

خرج Contrarian Investing (David Dreman)
Mar 26, 2026
خرج Defensive Investing (Benjamin Graham)
Mar 26, 2026
دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل Capital Light Compounder
Mar 24, 2026
دخل Contrarian Investing (David Dreman)
Mar 24, 2026
دخل Defensive Investing (Benjamin Graham)
Mar 24, 2026
دخل Value Investing (Warren Buffett)
Mar 24, 2026